National Clinical Amyloidosis Registry

National Clinical Amyloidosis Registry - NCAR

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035441

Enrollment

10000

Registered

2024-11-06

Start date

2018-01-02

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E85

Interventions

Group 1: patients with confirmed amyloidosis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: amyloidosis histological proven or positive sceletal scintigraphy

Exclusion criteria

Exclusion criteria: cerebral amyloidosis

Design outcomes

Primary

Measure	Time frame
incidence of amyloidosis disorders in Germany	—

Secondary

Measure	Time frame
Survival	—

Countries

Germany

Contacts

Public ContactUte Hegenbart

Universitäts-Klinikum

ute.hegenbart@med.uni-heidelberg.de+496221560

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026